Sanofi Pasteur MSD Limited

Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Patient Information Leaflet last updated on the eMC: 04/07/2011
PIL MMRVAXPRO

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Removal of Black Triangle
Updated on 21/05/2010 and displayed until 04/07/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to how the medicine works
  • Change to date of revision
Updated on 05/12/2008 and displayed until 21/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to MA holder contact details
Updated on 07/07/2008 and displayed until 05/12/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   measles, mumps and rubella vaccine (live)